Mylan Sued For Illegally Protecting EpiPen®’s Market Share

Published date02 May 2017
Law FirmPatterson Belknap Webb & Tyler LLP
AuthorWilliam F. Cavanaugh, Jr.,Terra Hittson
Subject MatterCompetition,Sherman Act,Anti-Monopoly,Mylan Pharmaceuticals,Antitrust Violations,Pharmaceutical Industry,Sanofi

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT